HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cardio-Oncology and Nuclear Cardiology
Cardio-Oncology and Nuclear Cardiology
Cardio-Oncology: Cardio-oncology is a study of cardiology that involves on the monitoring, detection and treatment of cardiovascular disease resulting as a side effect of chemotherapy and radiology. A number of cardiologists treat and manage patients with heart disease and cancer.
Nuclear Cardiology: Nuclear Cardiology studies use autoimmune techniques to evaluate myocardial blood flow, the pumping function of the heart as well as envision the size and location of a heart attack. Among all the techniques of nuclear cardiology, myocardial perfusion imaging is the mostly used.
Types of Nuclear Cardiology Tests:
- Cardiac SPECT
- Cardiac PET-CT
Committee Members
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States Cardio 2026 Speakers
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom